Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients
Arbele Limited
Arbele Limited
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
National Cancer Institute (NCI)
RasCal Therapeutics, Inc.
National Cancer Institute (NCI)
Continuity Biosciences, LLC
National Cancer Institute (NCI)
Washington University School of Medicine
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Eli Lilly and Company
Tomsk National Research Medical Center of the Russian Academy of Sciences
Institute of Cancer Research, United Kingdom
Kivu Bioscience Inc.
Alterome Therapeutics, Inc.
University of California, Davis
Boehringer Ingelheim
ViroMissile, Inc.
Arcus Biosciences, Inc.
Erasca, Inc.
PanTher Therapeutics
Changhai Hospital
Washington University School of Medicine
Case Comprehensive Cancer Center
Baylor Research Institute
National Institutes of Health Clinical Center (CC)
ArriVent BioPharma, Inc.
Dana-Farber Cancer Institute
Amgen
Eli Lilly and Company
Angiex, Inc.
Poseida Therapeutics, Inc.
H. Lee Moffitt Cancer Center and Research Institute
University of Rochester
University of Rochester
MacroGenics
Revolution Medicines, Inc.
Pheon Therapeutics
Boehringer Ingelheim
Abramson Cancer Center at Penn Medicine
University of Pennsylvania
General Oncology, Inc.
City of Hope Medical Center
SN BioScience
Zhejiang University
Cue Biopharma
Eli Lilly and Company
Eli Lilly and Company